Papers
Topics
Authors
Recent
Search
2000 character limit reached

Simplifying recombinant protein production: Combining Golden Gate cloning with a standardized protein purification scheme

Published 10 Oct 2023 in q-bio.BM | (2310.06456v1)

Abstract: Recombinant protein production is pivotal in molecular biology, enabling profound insights into cellular processes through biophysical, biochemical, and structural analyses of the purified samples. The demand for substantial biomolecule quantities often presents challenges, particularly for eukaryotic proteins. Escherichia coli expression systems have evolved to address these issues, offering advanced features such as solubility tags, posttranslational modification capabilities, and modular plasmid libraries. Nevertheless, existing tools are often complex, which limits their accessibility and necessitates streamlined systems for rapid screening under standardized conditions. Based on the Golden Gate cloning method, we have developed a simple 'one-pot' approach for the generation of expression constructs using strategically chosen tags like hexahistidine, SUMO, MBP, GST, and GB1 to enhance solubility and expression. Tags are removable via TEV protease cleavage, and the system allows visual cloning verification through mScarlet fluorescence. We provide a comprehensive protocol encompassing oligonucleotide design, cloning, expression, Ni-NTA affinity chromatography, and size-exclusion chromatography. This method therefore streamlines prokaryotic and eukaryotic protein production, rendering it accessible to standard molecular biology laboratories with basic protein biochemical equipment.

Citations (1)

Summary

No one has generated a summary of this paper yet.

Paper to Video (Beta)

No one has generated a video about this paper yet.

Whiteboard

No one has generated a whiteboard explanation for this paper yet.

Open Problems

We haven't generated a list of open problems mentioned in this paper yet.

Continue Learning

We haven't generated follow-up questions for this paper yet.